ResearcherCentre Hospitalier Universitaire de ReimsNo recent work listed
Sophie Deguelte
Matched on ORCID iD 0000-0001-8546-0433; OpenAlex author ID A5018815717. Sources: OpenAlex.
Their work
- Papers
- 2 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 7
2020: 1 paper · 2021: 1 paper
Papers 2
- Time from first seen in specialist care to surgery does not influence survival outcome in patients with upfront resected pancreatic adenocarcinoma. Last author DOI 10.1186/s12893-021-01409-7↗
- Time intervals to diagnosis and chemotherapy do not influence survival outcome in patients with advanced pancreatic adenocarcinoma. Co-author DOI 10.1016/j.dld.2020.03.014↗
Closest collaborators
The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Cindy Neuzillet · 2 shared papers, 2020–2021 · strength 0.21
- Paper Time from first seen in specialist care to surgery does not influence survival outcome in patients with upfront resecte… DOI 10.1186/s12893-021-01409-7↗
- Paper Time intervals to diagnosis and chemotherapy do not influence survival outcome in patients with advanced pancreatic ade… DOI 10.1016/j.dld.2020.03.014↗
- Mathias Brügel · 2 shared papers, 2020–2021 · strength 0.21
- Paper Time from first seen in specialist care to surgery does not influence survival outcome in patients with upfront resecte… DOI 10.1186/s12893-021-01409-7↗
- Paper Time intervals to diagnosis and chemotherapy do not influence survival outcome in patients with advanced pancreatic ade… DOI 10.1016/j.dld.2020.03.014↗
- Olivier Bouché · 2 shared papers, 2020–2021 · strength 0.21
- Paper Time from first seen in specialist care to surgery does not influence survival outcome in patients with upfront resecte… DOI 10.1186/s12893-021-01409-7↗
- Paper Time intervals to diagnosis and chemotherapy do not influence survival outcome in patients with advanced pancreatic ade… DOI 10.1016/j.dld.2020.03.014↗
- Patrick Pessaux · 1 shared paper, 2021 · strength 0.12
- Tullio Piardi · 1 shared paper, 2021 · strength 0.12
- Q. Laurent-Badr · 1 shared paper, 2020 · strength 0.09
- Louis de Mestier · 1 shared paper, 2020 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.